The startup provides transcranial magnetic stimulation (TMS) therapy in mental healthcare clinics to treat depression, anxiety, and OCD for patients who have not found relief from traditional antidepressants. This non-invasive treatment is covered by most insurance plans, offering a safe and effective alternative for individuals experiencing debilitating mental health symptoms.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients experiencing depression, anxiety, and OCD often do not find adequate relief from traditional antidepressant medications and talk therapy. These individuals require alternative treatment options to alleviate debilitating mental health symptoms.
Solution
Active Path Mental Health provides transcranial magnetic stimulation (TMS) therapy as a non-invasive, FDA-cleared treatment for individuals with treatment-resistant depression, anxiety, and OCD. TMS uses targeted magnetic pulses, similar to MRI technology, to stimulate specific brain regions responsible for mood regulation. This stimulation promotes increased neural activity, leading to a reduction in depressive symptoms. Treatment sessions are relatively short, allowing patients to resume their daily activities immediately following the procedure. Active Path also offers medication management and Spravato (esketamine) treatments, providing a comprehensive approach to mental healthcare.
Target Audience
The primary audience includes individuals aged 15 and older who have not found sufficient relief from depression, anxiety, or OCD through traditional treatments such as antidepressant medications and psychotherapy, as well as referring providers seeking alternative treatment options for their patients.
Features
- Non-invasive transcranial magnetic stimulation (TMS) for depression, anxiety, and OCD
- FDA-cleared treatment for patients with treatment-resistant conditions
- Utilizes magnetic pulses to stimulate specific brain areas associated with mood control
- Deep TMS (dTMS) option available, using BrainsWay technology, to stimulate deeper parts of the brain
- rTMS treatment using NeuroStar technology, with reduced treatment times
- Medication management services with psychiatric providers
- Spravato (esketamine) treatment for treatment-resistant depression, administered in a clinical setting
- Talk therapy services, including Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), and Dialectical Behavioral Therapy (DBT)
- Telehealth and in-person psychotherapy options available